about
Drug therapy of overactive bladder--what is coming next?Research Findings on Overactive BladderProstaglandin E2 excitatory effects on guinea pig urinary bladder smooth muscle: a novel regulatory mechanism mediated by large-conductance voltage- and Ca2+-activated K+ channelsThe effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder.Pathophysiology and animal modeling of underactive bladder.Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2.Rationale for the use of prostaglandins and phosphodiesterase inhibitors in the treatment of functional bladder disorders.Advanced therapeutic directions to treat the underactive bladder.Potential Future Pharmacological Treatment of Bladder Dysfunction.Effect of Selective Prostaglandin E2 EP2 Receptor Agonist CP-533,536 on Voiding Efficiency in Rats with Midodrine-Induced Functional Urethral Obstruction.The cardiovascular and gastrointestinal adverse effects of cyclooxygenase inhibitors seems to be a major concern that restricts their use in the treatment of urinary bladder dysfunction.High luteinizing hormone weakens urinary continence mechanisms in association with prostaglandin E2 elevation in a postmenopausal rat model.Urinary Bladder Hypertrophy is Susceptible in Male but Protected in Female ROMK Bartter's Mouse.OAB without an overactive bladder in the acute prostaglandin E2 rat model.Combination treatment of nocturnal enuresis with desmopressin and indomethacin.Inhibitory Effects of Urothelium-related Factors.
P2860
Q26780197-0E3FC18C-2A6F-4F97-84C3-529386E7F115Q26801459-E0CA5C04-2591-478D-8CB3-2CCC545BFBAAQ33934488-67D30097-06CB-4AE2-90DB-367279866F49Q34578718-4A608892-6544-4393-BC57-F023405C847BQ35747930-0B5C560B-AB7F-4C8E-9131-DBC5C88FD899Q35978080-42873FF3-52D7-45A5-BFE4-B9D24DEF0E78Q37639128-8BB8A650-14F4-4487-A3CE-06C062416C7AQ38252669-42E0BDDF-184F-4431-9F33-078F80AEFE1BQ38779624-710B598E-9451-411F-BB5A-58C3441B35BFQ39173562-0A1271DB-8C35-4BD3-90C9-5EA2C9E03F34Q39921978-3BBA2354-E5D0-4875-9340-17BE61B6981AQ47556255-E4417B86-A214-40E8-87DC-FCDFB6CFB6B4Q47577402-22E3E660-A4A4-4938-A8BD-43AC00B5A08BQ47678754-2E8CE808-A808-4663-B98C-CF2543911BB7Q48270605-E9DD7362-1388-4556-A88A-69126182D966Q50754128-B62F6F9E-E705-4379-9E65-2B8DB288F432
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The role of prostanoids in urinary bladder physiology.
@en
The role of prostanoids in urinary bladder physiology.
@nl
type
label
The role of prostanoids in urinary bladder physiology.
@en
The role of prostanoids in urinary bladder physiology.
@nl
prefLabel
The role of prostanoids in urinary bladder physiology.
@en
The role of prostanoids in urinary bladder physiology.
@nl
P2093
P2860
P356
P1476
The role of prostanoids in urinary bladder physiology.
@en
P2093
Gommert A van Koeveringe
Mohammad S Rahnama'i
Philip E V van Kerrebroeck
Stefan G de Wachter
P2860
P2888
P304
P356
10.1038/NRUROL.2012.33
P407
P577
2012-03-13T00:00:00Z
P5875
P6179
1050737489